An essential role for TAK1 in the contact hypersensitivity response

Cellular and Molecular Immunology

Volumn 8, Issue 4, 2011, Pages 315-324

  Zhao, Yan G ^a,b   Wang, Yunqi ^b   Hao, Weidong ^a   Wan, Yisong Y ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

2,4 dinitrofluorobenzene (DNFB); CHS; DC; TAK1

Indexed keywords

GAMMA INTERFERON; HAPTEN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTACT ALLERGY; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; INTERFERON PRODUCTION; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; DENDRITIC CELLS; DERMATITIS, CONTACT; HAPTENS; INTERFERON-GAMMA; MAP KINASE KINASE KINASES; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 79960059352     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2011.11     Document Type: Review

References (36)

1. Coenraads PJ, Goncalo M. Skin diseases with high public health impact. Contact dermatitis. Eur J Dermatol 2007; 17: 564-565.
2. Asano Y, Makino T, Norisugi O, Shimizu T. Occupational cobalt induced systemic contact dermatitis. Eur J Dermatol 2009; 19: 166-167.
3. Saint-Mezard P, Rosieres A, Krasteva M, Berard F, Dubois B, Kaiserlian D et al. Allergic contact dermatitis. Eur J Dermatol 2004; 14: 284-295. (Pubitemid 39222328)
4. Martin SF, Jakob T. From innate to adaptive immune responses in contact hypersensitivity. Curr Opin Allergy Clin Immunol 2008; 8: 289-293.
5. Jakob T, Ring J, Udey MC. Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 2001; 108: 688-696. (Pubitemid 33096196)
6. Xu H, DiIulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD81 T cells and interleukin (IL) 4/IL- 10-producing (Th2) negative regulatory CD41 T cells. J Exp Med 1996; 183: 1001-1012.
7. Trautmann A, Akdis M, Schmid-Grendelmeier P, Disch R, Brocker EB, Blaser K et al. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol 2001; 108: 839-846. (Pubitemid 33096219)
8. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD81 T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol 2002; 168: 3079-3087. (Pubitemid 34211691)
9. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005; 6: 1087-1095. (Pubitemid 41541786)
10. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 2005; 19: 2668-2681. (Pubitemid 41627934)
11. Skaug B, Jiang X, Chen ZJ. The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 2009; 78: 769-796.
12. Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol 2006; 7: 851-858. (Pubitemid 44084092)
13. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103: 239-252.
14. Schuman J, Chen Y, Podd A, Yu M, Liu HH, Wen Ret al. A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation. Blood 2009; 113: 4566-4574.
15. Landstrom M. The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol 2010; 42: 585-589.
16. Shapiro-Shelef M, Lin KI, Savitsky D, Liao J, Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med 2005; 202: 1471-1476. (Pubitemid 41746593)
17. Vooijs M, Jonkers J, Berns A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2001; 2: 292-297. (Pubitemid 32401523)
18. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. Eur J Dermatol 2009; 19: 325-332.
19. Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, Chavagnac C et al. CD81 T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 2006; 126: 815-820.
20. Martin S, LappinMB, Kohler J, Delattre V, Leicht C, Preckel T et al. Peptide immunization indicates that CD81 T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol 2000; 115: 260-266. (Pubitemid 30637196)
21. Traidl C, Sebastiani S, Albanesi C, Merk HF, Puddu P, Girolomoni G et al. Disparate cytotoxic activity of nickel-specific CD81 and CD41 T cell subsets against keratinocytes. J Immunol 2000; 165: 3058-3064.
22. Vocanson M, Hennino A, Chavagnac C, Saint-Mezard P, Dubois B, Kaiserlian D et al. Contribution of CD41 and CD81 T-cells in contact hypersensitivity and allergic contact dermatitis. Expert Rev Clin Immunol 2005; 1: 75-86.
23. Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Durr C et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med 2008; 205: 2151-2162.
24. Silverman N, Zhou R, Erlich RL, Hunter M, Bernstein E, Schneider D et al. Immune activation of NF-kappaB and JNK requires Drosophila TAK1. J Biol Chem 2003; 278: 48928-48934.
25. Hammaker DR, Boyle DL, Chabaud-Riou M, Firestein GS. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. J Immunol 2004; 172: 1612-1618. (Pubitemid 38116808)
26. Hammaker DR, Boyle DL, Inoue T, Firestein GS. Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther 2007; 9: R57.
27. Kimber I, Dearman RJ. Investigation of lymph node cell proliferation as a possible immunological correlate of contact sensitizing potential. Food Chem Toxicol 1991; 29: 125-129.
28. Gerberick GF, Cruse LW, Miller CM, Sikorski EE, Ridder GM. Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. Toxicol Appl Pharmacol 1997; 146: 1-10. (Pubitemid 27406391)
29. Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009; 64: 1699-1714.
30. Jiang Z, Zamanian-Daryoush M, Nie H, Silva AM, Williams BR, Li X. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J Biol Chem 2003; 278: 16713-16719. (Pubitemid 36799536)
31. Irie T, Muta T, Takeshige K. TAK1 mediates an activation signal from Toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages. FEBS Lett 2000; 467: 160-164. (Pubitemid 30081726)
32. Zanoni I, Granucci F. Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors. J Mol Med 2010; 88: 873-880.
33. Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, Graue N et al. Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes. J Biol Chem 2005; 280: 27728-27741. (Pubitemid 41076887)
34. Wan YY, Flavell RA. TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 2008; 28: 647-659.
35. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005; 6: 1219-1227. (Pubitemid 43045633)
36. Dubois B, Chapat L, Goubier A, Papiernik M, Nicolas JF, Kaiserlian D. Innate CD41CD251 regulatory T cells are required for oral tolerance and inhibition of CD81 T cells mediating skin inflammation. Blood 2003; 102: 3295-3301. (Pubitemid 37314769)